Absci and PrecisionLife Announce Strategic R&D Partnership to Jointly Develop AI-Enabled Drug Pipeline

<p>Leading AI biologics and precision medicine innovators will harness technologies to build a diverse portfolio of novel drug treatments With this partnership, Absci achieves 2023 outlook of ten new Active Programs signed for the year VANCOUVER, Wash., Dec. 20, 2023 (GLOBE NEWSWIRE) — Absci (Nasdaq: ABSI), a generative AI drug creation company, and PrecisionLife®, a […]</p>
<p>The post <a href="https://forextv.com/top-news/absci-and-precisionlife-announce-strategic-rd-partnership-to-jointly-develop-ai-enabled-drug-pipeline/">Absci and PrecisionLife Announce Strategic R&amp;D Partnership to Jointly Develop AI-Enabled Drug Pipeline</a> appeared first on <a href="https://forextv.com">ForexTV</a>.</p>